Clinical Trial Update: A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing azacitidine plus venetoclax versus stem cell transplant in adults aged 65 and older with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclyxto (Venetoclax)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING